{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-035693","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2022-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.440032+00:00","generated_at":"2026-06-24T22:19:04.147710+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Actinium amends at-the-market sales agreement, adds B. Riley Securities as agent","bullets":["Original Capital on Demand Sales Agreement (Aug 2020) allowed up to $200M in ATM offerings via JonesTrading.","A&R Sales Agreement dated June 28, 2022 adds B. Riley Securities as an additional sales agent.","No other material changes to terms; remaining $200M capacity unaffected.","Agreement filed as Exhibit 1.1; representations are for parties only, not factual disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-035693","json":"https://secwatch.observer/filing/0001213900-22-035693.json","markdown":"https://secwatch.observer/filing/0001213900-22-035693.md","text":"https://secwatch.observer/filing/0001213900-22-035693.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390022035693/0001213900-22-035693-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390022035693/ea161465-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:19:04.147710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}